Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program.

There are substantial potential cost savings from substituting brand-name medications with generic medications. These savings would be primarily driven by lower use of brand-name therapies by the minority of clinicians who prescribe them at increased rates.